(Q41929750)

English

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients with HCV Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

scientific article published on 22 September 2017

Statements

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients with HCV Genotype 2, 4, 5, or 6 Infection Without Cirrhosis (English)
Tarik Asselah
Neddie Zadeikis
Stanley Wang
Tarek Hassanein
Yves Horsmans
Massimo Colombo
Filipe Calinas
Humberto Aguilar
Victor de Ledinghen
Parvez S Mantry
Christophe Hezode
Rui Tato Marinho
Kosh Agarwal
Frederik Nevens
Magdy Elkhashab
Jens Kort
Teresa I Ng
Preethi Krishnan
Chih-Wei Lin
Federico J Mensa
22 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit